LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 39 filers reported holding LYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,836,352 | -2.6% | 4,050,218 | +2.3% | 1.35% | -14.0% |
| Q2 2023 | $16,265,497 | +264.4% | 3,957,542 | +78.2% | 1.57% | +359.9% |
| Q1 2023 | $4,463,868 | -36.0% | 2,220,830 | 0.0% | 0.34% | -24.3% |
| Q4 2022 | $6,973,406 | -38.0% | 2,220,830 | -1.1% | 0.45% | -37.9% |
| Q3 2022 | $11,252,000 | -16.0% | 2,245,830 | -5.2% | 0.73% | +8.5% |
| Q2 2022 | $13,389,000 | – | 2,369,668 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $12,484,000 | 9.72% |
| Perceptive Advisors | 3,222,561 | $36,543,000 | 0.59% |
| Soleus Capital Management, L.P. | 60,670 | $687,000 | 0.39% |
| PURA VIDA INVESTMENTS, LLC | 198,011 | $2,245,000 | 0.22% |
| RA Capital Management | 815,849 | $9,252,000 | 0.18% |
| ExodusPoint Capital Management, LP | 83,502 | $947,000 | 0.02% |
| ArrowMark Colorado Holdings LLC | 200,180 | $2,270,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 30,000 | $340,000 | 0.01% |
| Pentwater Capital Management LP | 23,800 | $270,000 | 0.01% |
| Blackstone Inc. | 25,000 | $284,000 | 0.00% |